PHARMACY

Diplomat receives ASHP accreditation for post-graduate residency program

BY Alaric DeArment

FLINT, Mich. — The American Society of Health System Pharmacists has granted accreditation to a post-graduate program offered by specialty pharmacy Diplomat, the company said.

Diplomat, which recently shortened its name from Diplomat Specialty Pharmacy, received ASHP accreditation for its postgraduate year one, or PGY1 pharmacy residency program.

"Our PGY1 pharmacy residency program, with a focus on specialty pharmacy, was established in 2011 as part of Diplomat’s training programs offered through Diplomat University," PGY1 program director Jennifer Hagerman said. "To receive the maximum length of accreditation from ASHP is a reflection of the resources Diplomat has committed to be a premier training institute for professionals within the specialty pharmacy industry, as well as the commitment of those involved in the program."

Before it implemented the PGY1 pharmacy residency program, the company had an accredited PGY1 community residency program, from 2007 to 2010. The current program takes place at Diplomat’s Flint, Mich., headquarters, lasts one year and emphasizes the development of advanced clinical skills within a specialty pharmacy setting. Residents also gain experience within ambulatory care and community settings, engaging in all aspects of pharmacy practice, including advanced-level clinical, operational and business activities. Residents also have the opportunity to complete a teaching certificate program through Ferris State University College of Pharmacy.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Onco360, MedImpact sign cancer-treatment deal

BY Alaric DeArment

NEW YORK — Cancer-focused specialty pharmacy Onco360 has signed a contract with privately owned pharmacy benefit manager MedImpact Healthcare Systems, whereby the pharmacy will offer its services to the PBM’s members.

The two companies said the partnership would offer MedImpact clients "a unique and effective solution for bending the cost curve," and was aimed at providing benefit payers with a proven and effective cancer pharmacy program that combines a cost-effective dispensing model with "clinical excellence."

"This is an exciting and timely collaboration, as the healthcare industry is at a crossroads, and the complexities of cancer care demand a novel solution," Onco360 CEO Burt Zweigenhaft said. "By addressing three key facets — fragmentation, coordination of care and cost control — we believe this comprehensive solution can have a positive effect for not just payers, but more importantly, the patients we put at the center of everything we do."

MedImpact president Greg Watanabe noted that the cost of cancer care was projected to increase to nearly $175 billion by 2020, a fourfold increase in less than a decade. The collaboration will bring the multidisciplinary approach used in many cancer treatment centers to the outpatient setting, featuring board-certified oncology pharmacists to provide coordination and clinical experience throughout the entire continuum of cancer care.

"Bringing together the oncology experience and expertise of Onco360 with the MedImpact approach to pharmacy benefit management will result in a unique and integrated benefit solution for oncology," Watanabe said. "With the coming changes of the Affordable Care Act and the heightened focus on delivering quality measures, it is clear to MedImpact and our clients that something needs to be done to more effectively manage the treatment and cost of cancer care."

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

NCPA recognizes three independent pharmacists for industry, community contributions

BY Michael Johnsen

ORLANDO, Fla. — The National Community Pharmacists Association on Monday recognized a number of independent operators for their contributions to the industry and their communities. 

California pharmacy owner I.R. Patel received the NARD Ownership Award from the NACP Foundation. The NARD Ownership Award, now in its second year, recognizes an independent pharmacist who embraces the entrepreneurial spirit through promotion and demonstrated excellence in the field of community pharmacy ownership. 

NCPA Foundation trustee Charles West with I.R. Patel

Mike James, the owner of two pharmacies in Raleigh, N.C., was honored as the recipient of the 2013 John W. Dargavel Medal. Sponsored by McKesson, this annual award honors an individual whose contributions on behalf of independent pharmacy embody the spirit of leadership and accomplishment personified by John Dargavel, who was executive secretary of the National Association of Retail Druggists, now NCPA, from 1933 to 1961. 

Tennessee’s Phil LaFoy, owner and president of Tennessee’s Blount Discount Pharmacy, was named the winner of the 2013 NCPA Prescription Drug Safety Award. Sponsored by Purdue Pharma, the award recognizes pharmacists who have reached out in their communities to provide education on the benefits of the correct use of prescription drug products and the hazards associated with their misuse.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?